A human study to evaluate the body fat-lowering effect and safety of Lactobacillus plantarum CKDB156

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003944

Enrollment

100

Registered

2019-05-17

Start date

2019-04-26

Completion date

Unknown

Last updated

2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Treatment: Capsule that contains the Lactobacillus plantarum CKDB156(2 capsules/time, 1 times/ day) Placebo: Placebo capsule that contains mainly crystalline cellulose without Lac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) 20 years= Age <65 years 3) 25 kg/m2 = BMI 30 kg/m2 4) Waist circumference = 90 cm (male) or 85 cm (female) 5) Subject who agreed not to receive any pharmacologic or non-pharmacologic treatment for reduction of body fat during study period

Exclusion criteria

Exclusion criteria: 1) Subject who have been continuously taken any medication that could affects body weight, lipid metabolism, blood glucose metabolism, immune function or inflammatory response within 1 month before the first visit, or who are likely to take them during the study period 2) Subject who have been continuously taken antibiotics within 2 months before the first visit, or who are likely to take them during the study period 3) Subjects who have been continuously consumed any healthy functional food or oriental medicine that can affect body weight, lipid metabolism, blood glucose metabolism or immune function within 1 month before the first visit. 4) Subjects who have been continuously consumed any food (including healthy functional food) that can affect bowel health within 1 month before the first visit. 5) Subjects with diseases such as uncontrolled hypertension, diabetes, liver dysfunction renal dysfunction hyperthyroidism and hypothyroidism serious central nervous system disorder, severe cardiovascular disease, etc.6) Subject who had irregular dietary or life habits 7) Recommended Food Score > 36, etc

Design outcomes

Primary

Measure	Time frame
Abdominal fat area, body;Blood indices (lipid profiles, leptin, etc)	—

Secondary

Measure	Time frame
Anthropometry	—

Countries

Korea, Republic of

Contacts

Public ContactMINKYOUNG KIM

Eulji University

mkk0526@naver.com+82-31-787-8349

Outcome results